Results 211 to 220 of about 12,719 (269)

Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV. [PDF]

Antimicrob Agents Chemother
Cossu MV, D'Avolio A, Gervasoni C, Giacomelli A, Cattaneo D, Moschese D.   +5 more
europepmc   +1 more source

Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level Viremia. [PDF]

J Acquir Immune Defic Syndr
Calza L, Colangeli V, Giglia M, Rigamonti C, Bon I, Cretella S, Viale P.   +6 more
europepmc   +1 more source

Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance. [PDF]

AIDS
Burger D, Wttewaal E, Oosterhof P, Stalenhoef J.   +3 more
europepmc   +1 more source

Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials. [PDF]

J Acquir Immune Defic Syndr
Moyle G, Meng F, Wan H, Sklar P, Plank RM, Lahoulou R.   +5 more
europepmc   +1 more source

Phenol (bio)isosteres in drug design and development. [PDF]

Arch Pharm (Weinheim)
Dunker C, Schlegel K, Junker A.
europepmc   +1 more source

Polynuclear cobalt complexes of 2-pyridones [PDF]

, 1994
Gilby, Liam Michael
core  

Metallaelectro-catalyzed alkyne annulations via C-H activations for sustainable heterocycle syntheses.

Chem Commun (Camb)
Kushwaha P, Saxena A, von Münchow T, Dana S, Saha B, Ackermann L.   +5 more
europepmc   +1 more source

An 8-year-old girl with secondary histiocytic sarcoma with BRAF^V600 mutation following T-cell acute lymphoblastic leukemia demonstrating stable disease for 3 years on dabrafenib and trametinib - a case report and literature review. [PDF]

BMC Pediatr
Tan SL, Ho BLS, Yew TT, Yunus D.
europepmc   +1 more source

Ketenimines as Aza-Dienophiles. [PDF]

J Am Chem Soc
DeAngelis CJ, Goyal G, Liss MJ, Budwitz JE, Herlihy MS, Conner AV, Wheeler SE, Ma P, Li M, Houk KN, Newton CG.   +10 more
europepmc   +1 more source

Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year. [PDF]

Future Microbiol
Esser S, Inciarte A, Levy I, D'Arminio Monforte A, Lambert JS, van Welzen B, Teruya K, Boffito M, Liu CE, Aydın OA, Thorpe D, Heinzkill M, Marongiu A, Cassidy T, Haubrich R, D'Amato L, Robineau O.   +16 more
europepmc   +1 more source